Abstract
Healthcare supply chains ensure that there is a cost-effective availability of medicines at healthcare facilities. However, it appears that public healthcare supply chains in South Africa are experiencing significant challenges in the management and distribution of the right medicines, at the right time, and at the right cost. This has resulted in poor healthcare outcomes. Moreover, public health supply chains also face major challenges due to rising patient expectations and inefficiencies in supply chain operations. There is recent interest in increasing public health supply chain efficiency and improving patient services. To address these challenges and opportunities, other studies have suggested the transformation of healthcare supply chains from the current pure ‘push’ approach into a ‘pull’ approach, which is driven by actual customer demand (demand-driven supply chain management DDSCM). However, no guidelines exist to support the design of DDSCM in public healthcare supply chains. Therefore, through a systematic literature review, this study aims to distinguish the key success factors for the DDSCM approach from those of other industries, and subsequently develops a framework to guide the design of DDSCM for the public healthcare sector.
Highlights
Through a systematic literature review, this study aims to distinguish the key success factors for the DDSCM approach from those of other industries, and subsequently develops a framework to guide the design of DDSCM for the public healthcare sector
South Africa is still burdened by a high human immunodeficiency virus (HIV) prevalence (13.06% in 2018) and a high incidence of cases of active TB (567 cases of active tubercle bacillus (TB) per 100 000 people in 2017)
The purpose of this paper was to identify the key success factors or capabilities for DDSCM that have been adopted in other industries, and to propose a framework that can be applied in public healthcare supply chains for the design and implementation of the DDSCM approach
Summary
South Africa is still burdened by a high human immunodeficiency virus (HIV) prevalence (13.06% in 2018) and a high incidence of cases of active TB (567 cases of active tubercle bacillus (TB) per 100 000 people in 2017). This means that stock-outs of medicines will have severe impacts on these affected populations. This has sparked interest in increasing public health supply chain efficiency and improving patient services [6]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have